Abstract

Cytomegalovirus (CMV) is the single most important infectious agent affecting recipients of organ transplants. To evaluate the incidence and the clinical importance of CMV infection in renal transplants in Brazil, 37 patients submitted to renal allograft transplants were tested periodically for the presence of cytomegalovirus DNA in urine using the polymerase chain reaction (PCR), and for the presence of IgM and IgG antibodies against CMV by enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence (IIF). The PCR-amplified products were detected by gel electrophoresis and confirmed by dot-blot hybridization with oligonucleotide probes. Thirty-two of the 37 patients (86.4%) were positive by at least one of the three methods. In six patients, PCR was the only test which detected the probable CMV infection. Ten patients had a positive result by PCR before transplantation. In general, the diagnosis was achieved earlier by PCR than by serologic tests. Active infection occurred more frequently during the first four months after transplantation. Sixteen of the 32 patients (50%) with active CMV infection presented clinical symptoms consistent with CMV infection. Five patients without evidence of active CMV infection by the three tests had only minor clinical manifestations during follow-up. Our results indicate that PCR is a highly sensitive procedure for the early detection of CMV infection and that CMV infection in renal transplant patients is a frequent problem in Brazil.

Highlights

  • Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality in immunosuppressed patients, among allograft recipients, whose number has increased markedly in recent years

  • In this paper we report the prevalence and clinical impact of CMV infection identified by serological tests and by polymerase chain reaction (PCR) in a Brazilian population of kidney transplant patients

  • Thirty-seven patients submitted to kidney transplantation at the Kidney Transplant Unit of the Department of Internal Medicine, University Hospital, State University of Campinas, SP, Brazil, were studied prospectively over a two-year period

Read more

Summary

Introduction

Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality in immunosuppressed patients, among allograft recipients, whose number has increased markedly in recent years. The ubiquity of this virus, its propensity to be reactivated when host defenses are compromised and its ability to disseminate to several organs are characteristics which help explain its frequent occurrence in the transplanted population. Numerous studies have shown that the majority of patients develop evidence of active CMV infection following kidney transplantation. Most of these individuals have asymptomatic infections, others have clinical manifestations of illness (overt CMV disease) ranging from high fever to death. In this paper we report the prevalence and clinical impact of CMV infection identified by serological tests and by PCR in a Brazilian population of kidney transplant patients

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call